This study was aimed at verifying the efficacy of EMS training by investigating the changes in upper-limb muscle functions and energy expenditure in athletes with disabilities after an 8-week intervention of EMS training. We compared variations in muscle activity, respiratory gas, and symmetry index (SI) after an 8-week intervention in eight professional male athletes with disabilities wearing an electromyostimulation (EMS) suit (age: 42.00 ± 8.67 years, height: 1.65 ± 0.16 m, weight: 64.00 ± 8.72 kg, career length: 11.75 ± 3.83 years). For EMS training, each participant wore an EMS suit. EMS was applied to the upper-limb muscles pectoralis major and triceps at 40 °C water temperature, with a 25 Hz frequency (duty cycle 10%) for 15 min, followed by a 5 Hz frequency (duty cycle 5%) for 5 min. The pre- and post-intervention measurements were taken in the same way at a pre-set time (for 1 h, twice a week) for 8 weeks. Training involved a seated chest press, and the muscle activity (pectoralis major, triceps, and antebrachial muscles), upper-limb SI, and respiratory gas variables (maximal oxygen consumption (VO₂), carbon dioxide output (VCO₂), respiratory quotient (RQ), metabolic equivalents (METs), and energy expenditure per min (Energy expended per minute; EEm)) were analyzed. Variations pre- and post-intervention across the measured variables were analyzed. Regarding the change in muscle activity, significant variations were found in the pectoralis major right (p < 0.004), pectoralis major left (p < 0.001), triceps right (p < 0.002), and antebrachial right (p < 0.001). Regarding left-to-right SI, a positive change was detected in the pectoralis major and triceps muscles. Additionally, respiratory gas analysis indicated significant variations in VO₂ (p < 0.001), VCO₂ (p < 0.001), METs (p < 0.001), and EEm (p < 0.001). EMS training improved muscle strength and respiratory gas variables and is predicted to contribute to enhanced muscle function and rehabilitation training for athletes with disabilities.

Background/Objectives: The study explored differences in gait characteristics and biomechanics according to rehabilitation aid use (normal gait (NG) vs. assisted gait (AG) groups) and obstacle height (0, 5, and 15 cm conditions) in patients with stroke-induced foot drop. Methods: A longitudinal study, within-subjects, repeated-measures study was conducted in 10 patients with mild foot drop. Participants walked at their preferred speed on a 10-m indoor track while crossing obstacles of three heights (0, 5, and 15 cm) under two gait conditions (normal walking (NG) and assisted walking (AG). The order of gait conditions and obstacle heights was randomized clinical within participants. Synchronized 3D motion capture with force plate measurements was used to calculate spatiotemporal variables, including ground reaction force (GRF), lower extremity joint angles at heel contact (HC), and toe-off (TO). A two-way repeated-measures ANOVA was used to examine the main effects and interaction effects of gait condition (NG vs. AG) and obstacle height (0, 5, and 15 cm). Results: AG showed little change in gait pattern, while there was a significant interaction between height and group. The vertical GRF (Fz) was lower in AG than NG at 5 cm, indicating reduced initial impact. There was a significant interaction for right medial–lateral (ML) GRF, with AG showing a small ML directional GRF over low obstacles (0–5 cm). At HC, AG was associated with an increase in right ankle dorsiflexion and right knee flexion. AG led to a reduction in left hip angle in the sagittal plane, and a smaller right ankle angle in the frontal plane, suppressing ML sway. At TO, AG caused an increase in right knee flexion, and bilateral ankle angles in the frontal plane at 5 cm. Conclusions: Rehabilitation aids reduced impact at initial contact, enhanced frontal plane stability, improved knee flexion and ankle alignment during the propulsion transition phase, and contributed to reduced variability and improved gait stability. The findings suggest potential utility for public health implications ambulation over curbs and thresholds, warranting larger, adequately powered clinical outcome trials.